Louise Goksøyr

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn et al. · Nature Communications · 2021 · 130 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization

Azad Farzadfard, Jannik Nedergaard Pedersen, Georg Meisl et al. · Communications Biology · 2022 · 67 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein

Sara R. Bang-Christensen, Rasmus S. Pedersen, Marina Ayres Pereira et al. · Cells · 2019 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +16

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

Merel J Smit, Adam F. Sander, Maud B P A Ariaans et al. · The Lancet Microbe · 2023 · 40 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines

Louise Goksøyr, Magdalena Skrzypczak, Maureen Sampson et al. · Vaccines · 2022 · 19 citations · Full text

Pharmacy, Immunology, Pharmaceutical Biotechnology +17